text.skipToContent text.skipToNavigation

Maximum quantity allowed is 999

Please select the quantity

CAS RN: 129830-38-2 | Product Number: Y0018

Y 27632 Dihydrochloride


Purity: >98.0%(HPLC)
Synonyms:
  • (1R,4r)-4-[(R)-1-Aminoethyl]-N-(pyridin-4-yl)cyclohexanecarboxamide Dihydrochloride
Product Documents:
50MG
¥1,790.00
1   Contact Us Contact Us

* For order or inquiry, please contact Our Authorized Distributors.
*TCI frequently reviews storage conditions to optimize them. Please note that the latest information on the storage temperature for the products is described on our website.
* To send your quote request for bulk quantities, please click on the "Request Bulk Quote" button. Please note that we cannot offer bulk quantities for some products.


Product Number Y0018
Purity / Analysis Method >98.0%(HPLC)
Molecular Formula / Molecular Weight C__1__4H__2__1N__3O·2HCl = 320.26 
Physical State (20 deg.C) Solid
Storage Temperature Refrigerated (0-10°C)
Store Under Inert Gas Store under inert gas
Condition to Avoid Light Sensitive,Hygroscopic,Heat Sensitive
CAS RN 129830-38-2
Reaxys Registry Number 9163222
PubChem Substance ID 468593133
MDL Number

MFCD03490488

Specifications
Appearance White to Almost white powder to crystal
Purity(HPLC) min. 98.0 area%
Water max. 8.0 %
NMR confirm to structure
Properties (reference)
Melting Point 252 °C(dec.)
Specific Rotation +4.0° (C=1,MeOH)
GHS
Related Laws:
Transport Information:
Customs Control Conditions (Q)
Application
Y-27632: A Rho associated Coiled-Coil Forming Protein Serine/Threonine Kinase (ROCK) Inhibitor

Y-27632 is a cell-permeable and selective Rho associated coiled-coil forming protein serine/threonine kinase (ROCK) inhibitor.1-4) ROCK is a serine-threonine protein kinase that has been identified as a target protein for the small GTP-binding protein Rho. It has been reported that ROCK is involved in various physiological function, including smooth muscle contraction and changes in cell morphology. ROCK inhibitors are expected to be applied to stem cell research reagents as well as to agents for hypertension and glaucoma. Y-27632 also inhibits LRRK2 (Leucine-rich repeat kinase 2) -G2019S that is a promising therapeutic target for the treatment of Parkinson's disease.5,6) (The product is for research purpose only.)

References


Documents

Product Documents (Note: Some products will not have analytical charts available.)
Safety Data Sheet (SDS)
Please select Language.

The requested SDS is not available.

Please Contact Us for more information.

Specifications
C of A & Other Certificates
Please enter Lot Number Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.

The product with the lot number searched for has been discontinued and related documentation is no longer provided. Please try a different lot number for this product.

Sample C of A
This is a sample C of A and may not represent a recently manufactured lot of the product.

A sample C of A for this product is not available at this time.

Analytical Charts
Please enter Lot Number Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.

The requested analytical chart is not available. Sorry for the inconvenience.

The product with the lot number searched for has been discontinued and related documentation is no longer provided. Please try a different lot number for this product.

Other Documents

Session Status
Your session will timeout in 10 minutes. You will be redirected to the HOME page after session timeout. Please click the button to continue session from the same page. minute. You will be redirected to the HOME page after session timeout. Please click the button to continue session from the same page.

Your session has timed out. You will be redirected to the HOME page.